<code id='0297214D25'></code><style id='0297214D25'></style>
    • <acronym id='0297214D25'></acronym>
      <center id='0297214D25'><center id='0297214D25'><tfoot id='0297214D25'></tfoot></center><abbr id='0297214D25'><dir id='0297214D25'><tfoot id='0297214D25'></tfoot><noframes id='0297214D25'>

    • <optgroup id='0297214D25'><strike id='0297214D25'><sup id='0297214D25'></sup></strike><code id='0297214D25'></code></optgroup>
        1. <b id='0297214D25'><label id='0297214D25'><select id='0297214D25'><dt id='0297214D25'><span id='0297214D25'></span></dt></select></label></b><u id='0297214D25'></u>
          <i id='0297214D25'><strike id='0297214D25'><tt id='0297214D25'><pre id='0297214D25'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:3

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Insitro, AI biotech unicorn, brings cash, new research to JPM 2024
          Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

          DaphneKoller,earlybiotechAIentrantInsitro'sfounder,CEOandboardmember.CourtesyJerrickMitra/InsitroNew

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          How a scoliosis diagnosis changed the life of one young dancer

          Photoillustration:CaseySheneryforSTATMaddyWelzalwayslovedtodance.Evenbeforeshelearnedhowtotieherowns